[{"address1": "1210-1220 Washington St.", "address2": "Suite 210", "city": "Newton", "state": "MA", "zip": "02465", "country": "United States", "phone": "617 344 4190", "website": "https://acumenpharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel J. O'Connell M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1047590, "exercisedValue": 0, "unexercisedValue": 1034567}, {"maxAge": 1, "name": "Dr. James  Doherty Ph.D.", "age": 56, "title": "President & Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 730785, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Zuga", "title": "CFO & Chief Business Officer", "fiscalYear": 2024, "totalPay": 703157, "exercisedValue": 0, "unexercisedValue": 254161}, {"maxAge": 1, "name": "Dr. Grant A. Krafft Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "totalPay": 42000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Caleb E. Finch Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William L. Klein Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Barton M.S.", "age": 66, "title": "Chief Operating Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 223680, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Carranza", "title": "Vice President, Finance & Accounting and Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alex  Braun M.B.A.", "title": "VP & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Derek M. Meisner Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 752945, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.95, "open": 1.96, "dayLow": 1.88, "dayHigh": 2.02, "regularMarketPreviousClose": 1.95, "regularMarketOpen": 1.96, "regularMarketDayLow": 1.88, "regularMarketDayHigh": 2.02, "payoutRatio": 0.0, "beta": 0.237, "forwardPE": -1.2287582, "volume": 53265, "regularMarketVolume": 53265, "averageVolume": 320438, "averageVolume10days": 168640, "averageDailyVolume10Day": 168640, "bid": 1.86, "ask": 1.93, "bidSize": 1, "askSize": 1, "marketCap": 113878040, "fiftyTwoWeekLow": 0.855, "fiftyTwoWeekHigh": 2.46, "allTimeHigh": 26.98, "allTimeLow": 0.855, "fiftyDayAverage": 1.8604, "twoHundredDayAverage": 1.38877, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18105040, "profitMargins": 0.0, "floatShares": 35610511, "sharesOutstanding": 60573425, "sharesShort": 1318100, "sharesShortPriorMonth": 1332676, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0218, "heldPercentInsiders": 0.070310004, "heldPercentInstitutions": 0.64767, "shortRatio": 4.74, "shortPercentOfFloat": 0.0293, "impliedSharesOutstanding": 60573425, "bookValue": 1.55, "priceToBook": 1.2129033, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -133351000, "trailingEps": -2.21, "forwardEps": -1.53, "enterpriseToEbitda": -0.131, "52WeekChange": -0.17021275, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 1.88, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 126609000, "totalCashPerShare": 2.09, "ebitda": -138170000, "totalDebt": 30836000, "quickRatio": 5.799, "currentRatio": 6.019, "debtToEquity": 33.095, "returnOnAssets": -0.42226002, "returnOnEquity": -0.85929, "grossProfits": -118928000, "freeCashflow": -78959504, "operatingCashflow": -123657000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ABOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Acumen Pharmaceuticals, Inc.", "longName": "Acumen Pharmaceuticals, Inc.", "regularMarketChangePercent": -3.58975, "regularMarketPrice": 1.88, "postMarketChange": 0.0020999908, "regularMarketChange": -0.0700001, "regularMarketDayRange": "1.88 - 2.02", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 320438, "fiftyTwoWeekLowChange": 1.025, "fiftyTwoWeekLowChangePercent": 1.1988304, "fiftyTwoWeekRange": "0.855 - 2.46", "fiftyTwoWeekHighChange": -0.58000004, "fiftyTwoWeekHighChangePercent": -0.23577237, "fiftyTwoWeekChangePercent": -17.021275, "messageBoardId": "finmb_8539521", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1625146200000, "postMarketChangePercent": 0.11170164, "postMarketPrice": 1.8821, "earningsTimestampStart": 1762867800, "earningsTimestampEnd": 1762867800, "earningsCallTimestampStart": 1755000000, "earningsCallTimestampEnd": 1755000000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.21, "epsForward": -1.53, "epsCurrentYear": -2.1271, "priceEpsCurrentYear": -0.88383245, "fiftyDayAverageChange": 0.019600034, "fiftyDayAverageChangePercent": 0.010535387, "twoHundredDayAverageChange": 0.49123, "twoHundredDayAverageChangePercent": 0.3537159, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-01", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1764367074, "regularMarketTime": 1764352801, "exchange": "NMS", "marketState": "CLOSED", "displayName": "Acumen Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]